Back | Next |
home / stock / nrbo / nrbo message board
Subject | By | Source | When |
---|---|---|---|
$NRBO MomentumIts trading | FROZENFLAME | investorshub | 01/27/2024 11:20:15 AM |
Time for this to show some returns | FROZENFLAME | investorshub | 01/27/2024 7:34:35 AM |
$NRBO MomentumIts trading last trade up | FROZENFLAME | investorshub | 01/27/2024 6:42:03 AM |
Looks pretty positive | SmellMyFinger | investorshub | 01/27/2024 2:41:08 AM |
bears and bulls | tw0122 | investorshub | 01/27/2024 1:21:42 AM |
$NRBO Price now last trade up | tw0122 | investorshub | 01/27/2024 1:09:54 AM |
Good read | tw0122 | investorshub | 01/26/2024 9:24:55 PM |
short data if anyone is interested | Invest-in-America | investorshub | 01/26/2024 3:24:01 PM |
$NRBO Price trading last trade up | tw0122 | investorshub | 01/26/2024 2:05:28 PM |
$NRBO what do you make of this data? | Invest-in-America | investorshub | 01/26/2024 11:15:37 AM |
$NRBO MomentumIts now | SmellMyFinger | investorshub | 01/26/2024 11:03:03 AM |
$NRBO Long and strong lets hope im right | db101 | investorshub | 01/26/2024 10:09:12 AM |
$NRBO Lets go go go go... Up up and away we go. | tw0122 | investorshub | 01/26/2024 7:43:26 AM |
short squeeze all day | SmellMyFinger | investorshub | 01/25/2024 10:40:19 PM |
What do you make of this? | SmellMyFinger | investorshub | 01/25/2024 8:31:26 PM |
Have a look at this | FROZENFLAME | investorshub | 01/25/2024 6:10:14 PM |
The gaining up | SmellMyFinger | investorshub | 01/25/2024 5:11:13 PM |
When is this gonna take off? | tw0122 | investorshub | 01/25/2024 4:38:21 PM |
The now | tw0122 | investorshub | 01/25/2024 6:47:24 AM |
$NRBO Time for a bounce? | SmellMyFinger | investorshub | 01/25/2024 5:35:59 AM |
News, Short Squeeze, Breakout and More Instantly...
NeuroBo Pharmaceuticals Inc. Company Name:
NRBO Stock Symbol:
NASDAQ Market:
NeuroBo Pharmaceuticals Inc. Website:
NeuroBo Pharmaceuticals Doses First Patient in the MAD Part 2 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity PR Newswire Top-Line Data Readout From the Single Ascending Dose Part 1 Expected in the Third Quarter of 2024, and From the Multiple Asce...
NeuroBo Pharmaceuticals Announces the Closing of up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire $20 million upfront with up to an additional $50 million of aggregate gross proceeds upon ...
NeuroBo Pharmaceuticals Announces up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire $20 million upfront with up to an additional $50 million of aggregate gross proceeds upon the exercise in...